Technology | Advanced Visualization | September 20, 2016

Riverain Technologies Earns FDA Approval for ClearRead CT Software

Device offers superior nodule detection performance and faster reading using a concurrent read for lung CT screening

Riverain Technologies, ClearRead CT, lung nodule detection software, FDA approval

September 20, 2016 — Riverain Technologies announced that its ClearRead CT, a breakthrough lung nodule detection application, has received clearance from the U.S. Food and Drug Administration (FDA).

ClearRead CT is the only FDA-cleared device to support concurrent reading, allowing for faster reading with proven superior automatic nodule detection performance for all primary nodule types, including solid, sub-solid and ground glass nodules.

ClearRead CT, powered by acquisition normalization technology, provides an enterprise-ready solution for the entire healthcare network. The technology seamlessly processes computed tomography (CT) scans from a wide range of manufacturers and acquisition protocols, and quickly installs into the clinical environment without the need for new hardware or customized tuning to specific devices or protocols.

ClearRead CT was evaluated in a multi-reader, multi-case clinical trial and showed radiologists achieved a 29 percent reduction in missed actionable nodules, while reducing reading time by 26 percent.

The software is comprised of two tools: ClearRead CT | Vessel Suppress and ClearRead CT | Detect. Deep learning enables the vessel suppression technology to assist both machine and humans in the detection and characterization of all primary nodule types, allowing for previously unattained nodule detection performance.

ClearRead CT is available for sale in the United States, Canada and Europe.

For more information: www.riveraintech.com

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Medivis Unveils AnatomyX Augmented Reality Education Platform
Technology | Advanced Visualization | April 02, 2019
Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform...
Sponsored Content | Videos | Advanced Visualization | April 01, 2019
GE Healthcare goes beyond core equipment maintenance to help clients solve some of their most important asset and cli
Novarad Names New President
News | Enterprise Imaging | March 29, 2019
Medical imaging software company Novarad announced that it has appointed Paul Jensen as company president.
Johns Hopkins Medicine First in U.S. to Install Canon Medical's Aquilion Precision
News | Computed Tomography (CT) | March 26, 2019
March 26, 2019 — Johns Hopkins Medicine now has access to the first...